TORONTO, March 13, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or “the Company”), a clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, has filed a lawsuit today against Mindset Pharma Inc. (“Mindset”) in the United States District Court for the District…


Previous articleBetterLife Files Amended and Restated Offering Document for Offering of Units
Next articleBetterLife Closes $1,857,143 of Private Placement